NeoGenomics has received expanded Medicare coverage for its RaDaR® ST molecular residual disease (MRD) assay to include monitoring of treatment response to immune checkpoint inhibitor therapy in patients with late-stage solid tumours.

IceCure Medical Ltd. developer of minimally-invasive cryoablation technology that destroys tumors by freezing as an option to surgical tumor removal, today announced that it has entered into an exclusive distribution agreement (the "Agreement") with Scovas Medical

ZEISS CLINIC 360, a cloud-based clinical data management solution from ZEISS Medical Technology, has received 510(k) clearance from the U.S. Food and Drug Administration (FDA).

Wellvii has received U.S. Food and Drug Administration (FDA) clearance for its BP Go blood pressure monitoring technology, designed to provide non-invasive blood pressure measurements using a finger-based approach instead of a traditional arm cuff.

Nanochon, a medical technology company developing Chondrograft™, a patented implant for treating knee cartilage defects, has received regulatory approval from Panama’s Ministry of Health to begin its first-in-human (FIH) clinical study in the country.

PercAssist, Inc., a medical device company developing extravascular biventricular mechanical circulatory support technology, has announced the successful enrolment of the first patient in its AVANXA Clinical Feasibility Study in São Paulo, Brazil.

GlobalMed and Iveda have entered into a strategic partnership to provide government agencies with integrated digital health, artificial intelligence and situational awareness technologies.

FastWave Medical has received approval from the US Food and Drug Administration (FDA) for its Investigational Device Exemption (IDE) application, allowing the company to begin a pivotal US clinical trial

Cardiologists from China and Indonesia have completed Southeast Asia's first complex chronic total occlusion (CTO) procedure using United Imaging Healthcare's uAngio AVIVA angiography system in Jakarta, Indonesia.

ZenoWell, a neurotechnology company incubated at Heidelberg University Medical School, has launched global pre-orders for Luna Plus, a wearable system that combines non-invasive vagus nerve stimulation (VNS)